Related Experiment Video
Updated: Mar 10, 2026

07:32
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
2.1K
Recent advances and future challenges in cancer immunotherapy
Namiko Okuyama1, Koji Tamada, Hideto Tamura
1Department of Immunology, Yamaguchi University Graduate School of Medicine.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|December 13, 2016
Summary
Cancer immunotherapy, including CAR-T cell therapy, shows promise but faces challenges. Future strategies focus on overcoming resistance and improving safety for broader patient benefit.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Cancer immunotherapy has advanced significantly, with CAR-T cell therapy and immune checkpoint inhibitors offering improved outcomes for some malignancies.
- Despite progress, challenges remain, including limited efficacy in low-immunogenic cancers and patient relapse, necessitating further innovation.
Purpose of the Study:
- To review recent advancements in cancer immunotherapy.
- To discuss future challenges and potential solutions for improving treatment efficacy, safety, convenience, and cost.
Main Methods:
- Discussion of novel therapeutic strategies.
- Review of ongoing clinical trials and emerging research in cancer immunotherapy.
Main Results:
- Chimeric antigen receptor-T (CAR-T) cell therapy and immune checkpoint inhibitors represent a paradigm shift in treating resistant cancers.
- Identification of neoantigens for personalized therapies and development of "armored" CAR-T cells show potential for enhanced clinical effects.
Conclusions:
- Further research is needed to develop more effective immunotherapies for challenging malignancies and to address patient relapse.
- Improving the safety, convenience, and cost-effectiveness of cancer immunotherapies is crucial for future clinical application.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K

